• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.

作者信息

Rinella Mary, Charlton Michael

机构信息

Northwestern University Medical Center, Chicago, IL.

Intermountain Medical Center, Salt Lake City, UT.

出版信息

Hepatology. 2016 Jul;64(1):19-22. doi: 10.1002/hep.28524. Epub 2016 Apr 4.

DOI:10.1002/hep.28524
PMID:26926530
Abstract
摘要

相似文献

1
The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.非酒精性脂肪性肝病的全球化：患病率及其对全球健康的影响。
Hepatology. 2016 Jul;64(1):19-22. doi: 10.1002/hep.28524. Epub 2016 Apr 4.
2
World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.世界胃肠病学组织全球指南：非酒精性脂肪性肝病和非酒精性脂肪性肝炎
J Clin Gastroenterol. 2014 Jul;48(6):467-73. doi: 10.1097/MCG.0000000000000116.
3
Prevalence of Nonalcoholic Fatty Liver Disease and Economy.非酒精性脂肪性肝病的患病率与经济状况
Dig Dis Sci. 2015 Nov;60(11):3194-202. doi: 10.1007/s10620-015-3728-3. Epub 2015 May 28.
4
Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes.非酒精性脂肪性肝病的全球流行病学：患病率、发病率及转归的Meta分析评估
Hepatology. 2016 Oct;64(4):1388-9. doi: 10.1002/hep.28584. Epub 2016 May 24.
5
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.非酒精性脂肪性肝病和非酒精性脂肪性肝炎在美国和世界其他地区的流行病学。
Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14.
6
[Non-alcoholic fatty liver disease (NAFLD)].非酒精性脂肪性肝病（NAFLD）
Dtsch Med Wochenschr. 2015 Jul;140(14):1051-5. doi: 10.1055/s-0041-102787. Epub 2015 Jul 16.
7
[Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease].[理想心血管行为/因素与非酒精性脂肪性肝病患病率之间的关系]
Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Jan;36(1):40-4.
8
Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和经济负担。
Clin Liver Dis. 2018 Feb;22(1):1-10. doi: 10.1016/j.cld.2017.08.001. Epub 2017 Oct 14.
9
Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications.非酒精性脂肪性肝病：流行病学、发病机制及治疗意义
J Med Life. 2018 Jan-Mar;11(1):20-23.
10
De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.肝移植后非酒精性脂肪性肝炎的新发与复发
Clin Liver Dis. 2017 May;21(2):321-335. doi: 10.1016/j.cld.2016.12.006. Epub 2017 Feb 1.

引用本文的文献

1
Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review.代谢功能障碍相关脂肪性肝病中的性别差异：一项叙述性综述。
Ewha Med J. 2024 Apr;47(2):e17. doi: 10.12771/emj.2024.e17. Epub 2024 Apr 30.
2
Modeling hepatic steatosis with human adult stem cell-derived liver organoids.利用人成体干细胞来源的肝类器官模拟肝脂肪变性
iScience. 2025 Apr 3;28(5):112344. doi: 10.1016/j.isci.2025.112344. eCollection 2025 May 16.
3
Ferroptosis as a key player in the pathogenesis and intervention therapy in liver injury: focusing on drug-induced hepatotoxicity.
铁死亡在肝损伤发病机制及干预治疗中的关键作用：聚焦药物性肝毒性
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 17. doi: 10.1007/s00210-025-04115-w.
4
Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review.类胡萝卜素通过肠道微生物群改善肥胖和脂肪性肝病：一篇叙述性综述。
Food Sci Nutr. 2025 Mar 10;13(3):e70092. doi: 10.1002/fsn3.70092. eCollection 2025 Mar.
5
High levels of serum dihomo-γ-linolenic acid are associated with non-alcoholic fatty liver disease in type 2 diabetic patients.2型糖尿病患者血清二高-γ-亚麻酸水平升高与非酒精性脂肪性肝病相关。
Diabetol Int. 2024 Nov 23;16(1):107-114. doi: 10.1007/s13340-024-00760-3. eCollection 2025 Jan.
6
Advances in the treatment of liver injury based on mesenchymal stem cell-derived exosomes.基于间充质干细胞衍生外泌体的肝损伤治疗进展
Stem Cell Res Ther. 2024 Dec 18;15(1):474. doi: 10.1186/s13287-024-04087-3.
7
Pediatric MASLD: current understanding and practical approach.小儿 MASLD：当前认识与实用方法。
Eur J Pediatr. 2024 Nov 19;184(1):29. doi: 10.1007/s00431-024-05848-1.
8
Normal caloric intake with high-fat diet induces metabolic dysfunction-associated steatotic liver disease and dyslipidemia without obesity in rats.正常热量摄入加高脂肪饮食可诱导大鼠出现代谢功能障碍相关脂肪性肝病和血脂异常，但不导致肥胖。
Sci Rep. 2024 Oct 1;14(1):22796. doi: 10.1038/s41598-024-74193-y.
9
Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism.脂质纳米颗粒介导的 CRISPR-Cas9 递送通过调节 CD36 及其甘油磷脂代谢改善非酒精性脂肪肝病。
Adv Sci (Weinh). 2024 Aug;11(31):e2400493. doi: 10.1002/advs.202400493. Epub 2024 Jun 18.
10
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.iATT 基于磁共振质子密度脂肪分数对肝脂肪变程度分级的定量研究：一项多中心研究。
J Gastroenterol. 2024 Jun;59(6):504-514. doi: 10.1007/s00535-024-02096-w. Epub 2024 Mar 30.